Evidence map›Paper›PMID 30626485›Full record

ArticleBiochemical and biophysical research communications2019

Connexin43 regulates osteoprotegerin expression via ERK1/2 -dependent recruitment of Sp1.

Aditi Gupta, Jenna M Leser, Nicole R Gould, Atum M Buo, Megan C Moorer, Joseph P Stains

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Aditi GuptaDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD, United States. Electronic address: adgupta@som.umaryland.edu.
Jenna M LeserDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD, United States. Electronic address: jleser@umaryland.edu.
Nicole R GouldDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD, United States. Electronic address: ngould@umaryland.edu.
Atum M BuoDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD, United States. Electronic address: ab6cx@virginia.edu.
Megan C MoorerDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD, United States. Electronic address: mmoorer1@jhmi.edu.
Joseph P StainsDepartment of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD, United States. Electronic address: jstains@som.umaryland.edu.
University of Maryland, Baltimore · US

Funding

TRAINING PROGRAM IN INTEGRATIVE MEMBRANE BIOLOGYT32GM008181 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI RIZZO, MEGAN A, TRUDEAU, MATTHEW C · 1987 to 2022
$4.9M
Spatial Control of Bone Remodeling by Gap Junction-Communicated cAMPR01AR063631 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI STAINS, JOSEPH P. · 2013 to 2024
$3.3M
Osteocyte CaMKII as a Critical Regulator of Bone Physiology and AnabolismR01AR071614 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Joseph P. Stains · 2018 to 2026
$2.6M
NIAMS NIH HHS R01 AR063631NIAMS NIH HHS R01 AR071614NIGMS NIH HHS T32 GM008181
6 · The paper itself

Abstract

In bone, connexin43 expression in cells of the osteoblast lineage plays an important role in restraining osteoclastogenesis and bone resorption. While there is a consensus around the notion that the anti-osteoclastogenic factor, osteoprotegerin, is a driver of this effect, how connexin43 regulates osteoprotegerin gene expression is unclear. Here, we show that loss of connexin43 decreased osteoprotegerin gene expression and reduced ERK1/2 activation. Conversely, overexpression of connexin43 increased osteoprotegerin expression and enhanced ERK1/2 activation. This increase in phospho-ERK1/2 is required for connexin43 to induce transcription from the osteoprotegerin proximal promoter. Connexin43 increased promoter activity via a specific 200 base pair region of the osteoprotegerin promoter located at -1486 to -1286 with respect to the transcriptional start site, a region which includes four Sp1 binding elements. Further, activation of this promoter region required an intact functional connexin43, as hypomorphic or dominant negative connexin43 mutant constructs, including one with increased hemichannel activity, were unable to stimulate osteoprotegerin expression as strongly as wild type connexin43. Using chromatin immunoprecipitations, we show that connexin43 expression enhanced the recruitment of Sp1, but not Runx2, to the osteoprotegerin proximal promoter. In total, these data show that connexin43-dependent gap junctional communication among osteoblast cells permits efficient ERK1/2 activation. ERK1/2 signaling promotes the recruitment of the potent transcriptional activator, Sp1, to the osteoprotegerin proximal promoter, resulting in robust transcription of anti-osteoclastogenic factor, osteoprotegerin.

Indexed as

Transcriptional ActivationAnimalsCells, CulturedConnexin 43Mice, Inbred C57BLMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3OsteoblastsOsteoprotegerinPromoter Regions, GeneticSp1 Transcription FactorConnexin 43Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3OsteoprotegerinSp1 Transcription FactorConnexin43Gap junctionsOsteoblastOsteoclastOsteoprotegerin

Identifiers

PMID30626485
PMCPMC6369926
OpenAlexW2909383090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.